Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1612 1614 1615 1621 1626 1627 1672
This examiner grants 85% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18551809 | COMPOSITE DRUG PARTICLES AND USES THEREOF | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 19033776 | UTILIZATION OF NANOPARTICLES IN TARGETED THERAPY | Non-Final OA | Alcon Inc. |
| 18285439 | IMMUNOFUNCTIONAL CARRIER, METHODS OF USES, AND COMPOSITION MATTERS AS AN ANTITUMOR IMMUNOTHERAPY | Non-Final OA | Purdue Research Foundation |
| 18880931 | Liquid Emulsion Comprising Ethylcellulose, a Natural Resin, a Liquid Fatty Alcohol, a Solid Ester and/or a Polar Hydrocarbon-Based Oil and Process Using Same | Non-Final OA | L'OREAL |
| 18870026 | HAIR TREATMENT METHOD FOR LIMITING THE CALCIUM CONTENT OF THE HAIR | Non-Final OA | L'OREAL |
| 18987189 | GROWTH FACTOR LOADED NANOFIBERS AND METHODS OF USE THEREOF | Non-Final OA | Board of Regents of the University of Nebraska |
| 18856855 | BIODEGRADABLE LIPIDOIDS AND COMPOSITIONS AND METHODS OF USE THEREOF FOR TARGETED DELIVERY | Non-Final OA | The Trustees Of The University Of Pennsylvania |
| 18044269 | FLOCCULANT BASED DISINFECTION PROCESS FOR PATHOGENIC MEDICAL WASTE DISPOSAL | Final Rejection | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH |
| 18703046 | METHOD FOR PRODUCING EMULSION COMPOSITION | Non-Final OA | KAO CORPORATION |
| 18291488 | PULSE PROTEIN-BASED COMPOSITION FOR ACTIVATING THE SYNTHESIS OF FGF19 | Non-Final OA | ROQUETTE FRERES |
| 18725296 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOSITIONS | Non-Final OA | GIVAUDAN SA |
| 18919039 | NOVEL PHARMACEUTICAL FORMULATIONS | Non-Final OA | AUSPEX PHARMACEUTICALS, INC. |
| 18727893 | TEETH WHITENING COMPOSITION WITH VITAMINS | Final Rejection | IDS RESEARCH SOCIETA' A RESPONSABILITA' LIMITATA |
| 18570579 | Self-Assembling Nanoparticles Based On Amphiphilic Peptides for Drug Delivery Applications | Non-Final OA | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC |
| 18042743 | METHODS TO PRODUCE VERY LONG CHAIN FATTY ACIDS (VLCFA) | Non-Final OA | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN |
| 18776606 | CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | Non-Final OA | Celgene Corporation |
| 18831041 | Formulated and/or Co-Formulated Nanocarrier Compositions Containing TFGß Antagonist Prodrugs Useful in the Treatment of Cancer and Methods Thereof | Final Rejection | Nammi Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy